文献速递糖尿病

1型糖尿病运动后血糖控制与残余β细胞功能相关

Postexercise Glycemic Control in Type 1 Diabetes Is Associated With Residual β-Cell Function.
PubMed 文献 · Diabetes Care · 2020-08-03

研究纳入30例病程≥3年的1型糖尿病患者,按混合餐试验刺激后C肽峰值分为不可测组(<3 pmol/L)、低值组(3-200 pmol/L)和高值组(>200 pmol/L),评估45分钟斜坡平板步行(60% VO2peak)后48小时连续葡萄糖监测(CGM)指标。高C肽组运动后12小时和24小时血糖3.9-10 mmol/L时间显著多于低值组和不可测组,高血糖时间和血糖变异性显著更低;运动后24小时CGM指标变化在高值组改善(+12.1%),而低值组和不可测组恶化(-16.2%和-9.1%)。

要点

  • 高C肽组运动后12小时血糖3.9-10 mmol/L时间73.5±27.6%,显著高于低值组43.6±26.1%(P=0.027)和不可测组40.6±17.0%(P=0.010)。
  • 高C肽组运动后24小时高血糖时间和血糖变异性显著低于不可测组和低值组(P<0.05和P<0.01)。
  • 运动后24小时血糖3.9-10 mmol/L时间变化:高值组+12.1%,低值组-16.2%,不可测组-9.1%(P=0.017)。

核心结论

  • 残余β细胞功能可能部分解释1型糖尿病患者运动急性血糖获益的个体间差异。
  • 量化C肽可能有助于为运动患者提供个性化和有针对性的支持。

研究设计与样本

  • 研究纳入30例病程≥3年的1型糖尿病患者,先进行7天自由生活盲法CGM数据采集,再行3小时混合餐试验评估刺激后C肽和胰高血糖素,按C肽峰值分为不可测组(<3 pmol/L)、低值组(3-200 pmol/L)和高值组(>200 pmol/L),最后完成45分钟斜坡平板步行(60% VO2peak)后48小时CGM采集。

主要发现

  • 自由生活观察周期间各组CGM参数相当。
  • 运动后12小时和24小时,高C肽组血糖3.9-10 mmol/L时间(12小时73.5±27.6%;24小时76.3±19.2%)显著多于低值组(12小时43.6±26.1%,P=0.027;24小时52.3±25.0%,P=0.067)和不可测组(12小时40.6±17.0%,P=0.010;24小时51.3±22.3%,P=0.041)。
  • 高C肽组运动后12小时和24小时高血糖时间(血糖>10和>13.9 mmol/L,P<0.05)和血糖变异性(12小时和24小时SD,P<0.01)显著低于不可测组和低值组。
  • 运动前至运动后24小时CGM指标变化各组不同:不可测组和低值组血糖3.9-10 mmol/L时间分别恶化-9.1%和-16.2%,高值组改善+12.1%(P=0.017)。

临床怎么用

  • 作者认为,量化C肽可能有助于为运动患者提供个性化和有针对性的支持。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the impact of residual β-cell function on continuous glucose monitoring (CGM) outcomes following acute exercise in people with type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS: Thirty participants with T1D for ≥3 years were recruited. First, participants wore a blinded CGM unit for 7 days of free-living data capture. Second, a 3-h mixed-meal test assessed stimulated C-peptide and glucagon. Peak C-peptide was used to allocate participants into undetectable (Cpepund <3 pmol/L), low (Cpeplow 3-200 pmol/L), or high (Cpephigh >200 pmol/L) C-peptide groups. Finally, participants completed 45 min of incline treadmill walking at 60% VO2peak followed by a further 48-h CGM capture. RESULTS: CGM parameters were comparable across groups during the free-living observation week. In the 12- and 24-h postexercise periods (12 h and 24 h), the Cpephigh group had a significantly greater amount of time spent with glucose 3.9-10 mmol/L (12 h, 73.5 ± 27.6%; 24 h, 76.3 ± 19.2%) compared with Cpeplow (12 h, 43.6 ± 26.1%, P = 0.027; 24 h, 52.3 ± 25.0%, P = 0.067) or Cpepund (12 h, 40.6 ± 17.0%, P = 0.010; 24 h, 51.3 ± 22.3%, P = 0.041). Time spent in hyperglycemia (12 h and 24 h glucose >10 and >13.9 mmol/L, P < 0.05) and glycemic variability (12 h and 24 h SD, P < 0.01) were significantly lower in the Cpephigh group compared with Cpepund and Cpeplow. Change in CGM outcomes from pre-exercise to 24-h postexercise was divergent: Cpepund and Cpeplow experienced worsening (glucose 3.9-10 mmol/L: -9.1% and -16.2%, respectively), with Cpephigh experiencing improvement (+12.1%) (P = 0.017). CONCLUSIONS: Residual β-cell function may partially explain the interindividual variation in the acute glycemic benefits of exercise in individuals with T1D. Quantifying C-peptide could aid in providing personalized and targeted support for exercising patients.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Taylor GS, Smith K, Capper TE, et al. Postexercise Glycemic Control in Type 1 Diabetes Is Associated With Residual β-Cell Function. Diabetes Care. 2020. PMID: 32747405. doi:10.2337/dc20-0300

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。